Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-24 @ 2:11 PM
NCT ID:
NCT01772095
Eligibility Criteria:
Inclusion Criteria:
* Age 50 and older
* Diagnosis of dementia
* Rating 15\<MMSE\<24
* The patient has reliable caregivers
* Signed consent form to participate in the study after informed by reliable caregivers of the patient or another witness
* The patient is on treatment with donepezil for at least one month prior to joining the clinical trial
Exclusion Criteria:
* Severe gastrointestinal, kidney, hepatic, endocrine, pulmonary, or hematologic disease.
* Other primary psychiatric or neurological disorder.
* Clinically significant laboratory and ECG abnormalities.
* Participation in another clinical study than this
* Refusal to sign the consent form to participate in the study after informed by reliable caregivers of the patient or another witness
* The patient is on treatment with donepezil for less than a month before its integration in the clinical study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
95 Years
Study:
NCT01772095
Study Brief:
Protocol Section:
NCT01772095